drug
ENJUVIA
Marketedupdated 3mo agoby $ASPU ASPEN GROUP, INC.
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2all catalysts(9)
approval · 9
May 10, 2004
approval
$ASPU0.2893-0.26%
ENJUVIA (ESTROGENS, CONJUGATED SYNTHETIC B) — FDA approval
ENJUVIA
→
Apr 23, 2007
approval
$ASPU0.2893-0.26%
ENJUVIA (ESTROGENS, CONJUGATED SYNTHETIC B) — FDA approval
ENJUVIA
→
Apr 27, 2007
approval
$ASPU0.2893-0.26%
ENJUVIA (ESTROGENS, CONJUGATED SYNTHETIC B) — FDA approval
ENJUVIA
→
Jun 30, 2015
approval
$ASPU0.2893-0.26%
ENJUVIA (ESTROGENS, CONJUGATED SYNTHETIC B) — FDA approval
ENJUVIA
→
Nov 1, 2017
approval
$ASPU0.2893-0.26%
ENJUVIA (ESTROGENS, CONJUGATED SYNTHETIC B) — FDA approval
ENJUVIA
→
Nov 30, 2020
approval
$ASPU0.2893-0.26%
ENJUVIA (ESTROGENS, CONJUGATED SYNTHETIC B) — FDA approval
ENJUVIA
→
Nov 30, 2020
approval
$ASPU0.2893-0.26%
ENJUVIA (ESTROGENS, CONJUGATED SYNTHETIC B) — FDA approval
ENJUVIA
→
Feb 15, 2024
approval
$ASPU0.2893-0.26%
ENJUVIA (ESTROGENS, CONJUGATED SYNTHETIC B) — FDA approval
ENJUVIA
→
Feb 12, 2026
approval
$ASPU0.2893-0.26%
ENJUVIA (ESTROGENS, CONJUGATED SYNTHETIC B) — FDA approval
ENJUVIA
→
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 38m ago
Found something off?
comments(0)
5-min edit window · permanent after that